1
Home
Companies

Okyo Pharma

#9444

Rank

$80.86M

Marketcap

GB United Kingdom

Country

Okyo Pharma
Leadership team

Dr. Gary S. Jacob Ph.D. (CEO & Exec. Director)

Mr. Michael Paul Beck (Founder)

Ms. Keeren Shah (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Headquarters
London, England, United Kingdom
Established
2007
Company Registration
SEC CIK number: 0001849296
Traded as
OKYO
URL
https://www.okyopharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
History

Otsuka Pharmaceutical Co., Ltd. was founded in 1921 as a small mom-and-pop drug store in Tokyo. Today, the global Otsuka Group, which includes Okyo Pharma, produces a wide variety of medicines, nutritionals and healthcare products in nearly 50 countries and geography and is the largest pharmaceutical company in Japan.

Mission
Okyo Pharma’s mission is to be a leader in creating for people worldwide the best healthcare solutions based on scientific evidence, our technology and the spirit of Otsuka.
Vision
Okyo Pharma is committed to becoming a world-leading healthcare company, dedicated to providing products and services that create maximum value for all of our stakeholders.
Key Team

Dr. Rajkumar Patil Ph.D. (Chief Scientific Officer)

Recognition and Awards
Otsuka Pharmaceutical has won numerous awards, including being named one of the “Most Admired Pharmaceuticals in the World” by Fortune in 2013, the Excellent Quality Award from the Japanese Society of Clinical Chemistry in 2016, and the Takasago Award from the American Society of Pharmaceutical Research in 2017.
References

https://in.investing.com/equities/okyo-pharma-adr

https://finance.yahoo.com/quote/OKYO.L/profile?p=OKYO.L

https://www.crunchbase.com/organization/okyo-pharma

https://companiesmarketcap.com/

https://www.okyopharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Okyo Pharma
Leadership team

Dr. Gary S. Jacob Ph.D. (CEO & Exec. Director)

Mr. Michael Paul Beck (Founder)

Ms. Keeren Shah (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Headquarters
London, England, United Kingdom
Established
2007
Company Registration
SEC CIK number: 0001849296
Traded as
OKYO
URL
https://www.okyopharma.com